2cureX investor relations material

2cureX AB operates as a medtech company in Europe. The Company focuses on the development and marketing of medical products used to treat chronic wounds and burns. Its primary product is 2cureX Wound Gel; a wound care treatment that utilizes biocompatible polymer foam matrix technology to create a semi-permeable dressing specifically designed for chronic wounds that promotes healing, protects healthy tissue and helps reduce bacterial colonization. 2cureX AB was incorporated in 2006 and is based in Copenhagen, Denmark.